OOIR: Observatory of International Research

Papers

(The median citation count of Cancer Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Social Drivers of Cancer Risk and Outcomes Among African American Men	111
PET Imaging of Metabolism, Perfusion, and Hypoxia	47
Oncology Physician Workforce Diversity	27
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	23
Toxicities From Antibody-Drug Conjugates	23
Clinical Evidence Generation During a Pandemic	22
Building a Bridge to Equity in Health and Health Care in Cancer Care	22
Health Care Policy and Disparities in Health	20
Stereotactic Body Radiation Therapy	19
Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia	18
Nonoperative Management for Rectal Cancer	18
Melanoma—Modern Treatment for Metastatic Melanoma	18
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	17
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	16
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	14
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	14
Metastatic Melanoma Treatment in Special Populations	14
Germline Predisposition to Myelodysplastic Syndromes	13
Diversity in Cancer Care	13
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care	12
Rectal Cancer—The Only Constant Is Change	12
Antibody Drug Conjugates in Multiple Myeloma	12
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer	12
Primary Prevention of Cancer	12
Prostate Cancer, Race, and Health Disparity	12

How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia	11
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer	10
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes	10
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer	10
Overview of the Management of Higher-Risk Myelodysplastic Syndromes	10
Are We Witnessing a Paradigm Shift in the Treatment of Acute Myeloid Leukemia?	10
Supportive Care for Patients With Myelodysplastic Syndromes	9
New Metabolomic Insights Into Cancer	9
Advances in Stereotactic Body Radiation Therapy for Lung Cancer	9
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	9
Updates in the Management of Uveal Melanoma	9
Discovery of Natural Products for Cancer Prevention	8
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	8
Introduction	8
Impact of Precision Medicine in Oncology	8
Menopausal Hormone Therapy and Breast Cancer	8
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	8
Telehealth and Technology	7
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	7
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms	7
How Far We’ve Come	7
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	7
Role of the Microbiome in Immunotherapy of Melanoma	7
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	7
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	7
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	7
Hormone Replacement Therapy After Breast Cancer	7
Current State of Cell Therapies for Genitourinary Malignancies	6
Molecular Imaging of Steroid Receptors in Breast Cancer	6
STING Agonists in Head and Neck Squamous Cell Carcinoma	6
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?	6
What to Eat for Cancer Prevention	6
Estrogen for the Treatment and Prevention of Breast Cancer	6
Gene Expression Profiles in Cancers and Their Therapeutic Implications	6
Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development	6
Telemedicine Across the Cancer Care Continuum	6
Repurposing Drugs for Cancer Prevention	6
Telemedicine and Cancer Care	6
Survival of the Fittest	6
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation	5
Updates in Classification of Myelodysplastic Syndrome	5
Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases	5
Impact of Precision Medicine in Oncology	5
The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment	5
The Clinical Value of Plasma Epstein-Barr Virus DNA as a Tumor Marker in Nasopharyngeal Carcinoma: Prognostic? Yes, But How Can We Best Use It?	5
Concerns About Compounded Bioidentical Menopausal Hormone Therapy	5
The Gut Microbiome and Pancreatic Cancer Development and Treatment	5
Antibody-Drug Conjugates in Myeloid Leukemias	5
The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation	5
Beyond the COVID-19 Pandemic	5

Adoptive Cell Therapy for Advanced Solid Tumors	5
Local Excision for Early-Stage Rectal Adenocarcinomas	5
Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer	5
Chimeric Antigen Receptor T-Cell Therapy	4
Evolution of Response-Based Radiotherapy for Hepatocellular Cancer	4
Menin Inhibitors in Acute Myeloid Leukemia—What Does the Future Hold?	4
Effective Image Communication of Hormone Replacement Therapy Risks and Benefits	4
Advancements in Understanding and Preventing Obesity-Related Colon Cancer	4
Radiopharmaceuticals for Cancer Diagnosis and Therapy	4
Management of Low-Grade Gliomas	4
The Management of Low-Risk Myelodysplastic Syndromes—Current Standards and Recent Advances	4
Digital Health for Oncological Care	4
Introduction	4
Epidemiology and Pathogenesis of Myelodysplastic Syndrome	4
The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma	4
Nuclear Medicine Cancer Care—Current Status and Future Directions for Radiopharmaceutical Diagnostics and Theranostics for Cancer	3
Antibody-Drug Conjugates and Tissue-Agnostic Drug Development	3
Telemedicine and Burnout—How Enhancing Operational Support Can Improve Digital Health Tools	3
The Promise of Cancer Health Justice	3
Diversity and Disparities in Lung Cancer Outcomes Among Minorities	3
Treatment of Stage III Resectable Melanoma—Adjuvant and Neoadjuvant Approaches	3
The Evolving Role of Allogeneic Stem Cell Transplant in the Era of Molecularly Targeted Agents	3
Shifting the Landscape of Spine and Non-Spine Bone Metastases	3
Targets for Cancer Prevention: Evolving Methodologies in Basic and Epidemiological Sciences Identify Interrelated Pathways and the Need for Holistic Approaches	3
The Menopause Management Vacuum	3
Neoantigen-Specific T Cells in Adoptive Cell Therapy	3
Checkpoint Inhibitors and Other Immune-Based Therapies in Acute Myeloid Leukemia	3
Preclinical In Vitro and In Vivo Models for Adoptive Cell Therapy of Cancer	3
Fecal Microbiota Transplantation as a Cancer Therapeutic	3
The Role of Circulating Tumor DNA for Management of Patients With Rectal Cancer	3
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine	3